Bioavailability study of 7-day rasagiline patch (TPU-002RA)

Trial Profile

Bioavailability study of 7-day rasagiline patch (TPU-002RA)

Phase of Trial: Phase I

Latest Information Update: 10 Dec 2014

At a glance

  • Drugs Rasagiline (Primary) ; Rasagiline
  • Indications Parkinson's disease
  • Focus Pharmacokinetics; Registrational
  • Sponsors Teikoku Pharma USA
  • Most Recent Events

    • 10 Dec 2014 New trial record
    • 02 Dec 2014 Results published in Teikoku Pharma USA media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top